1Berger M. A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies [J]. Curr Allergy Asthma Rep, 2002, 2(5) :368-378.
2Buckley RH, Schiff RI. The use of intravenous immune globu- lin in immunodeficiency diseases [J]. N Engl J Med, 1991, 325(2) : 110-117.
3Patel JA, Ghatak SB. Pexelizumab and its role in the treat- ment of myocardial infarction and in coronary artery bypass graft surgery: a review [J]. Recent Pat Cardiovasc Drug Discov, 2008, 3(2):145-152.
4Ebadi H, Barth D, Bril V. Safety of plasma exchange therapy in patients with myasthenia gravis [J]. Muscle Nerve, 2013, 47(4) :510-514.
5Eibl MM. History of immunogloblin replacement [J]. Immunol Allergy Clin North Am, 2008, 28(4) :737-764.
6Black CA. A brief history of the discovery of the immuno- globulins and the origin of the modern immunoglobulin nomen- clature [J]. Immunol Cell Biol, 1997, 75(1) :65-68.
7Wallenius G, Trautman R, Kunkel HG, et al. Ultraeentrifu- gal studies of major non-lipide electrophoretic components ofnormal human serum [J]. J Biol Chem, 1957, 225(1):253- 267.
8Morris W. The American heritage dictionary of the English language [M]. 4th ed. Boston: Hoghton Mifflin, 2000.
